(Q38880808)

7 September 2017

title

Adverse reactions to the ivermectin treatment of onchocerciasis patients: does infection with the human immunodeficiency virus play a role? (English)

1 reference

7 September 2017

0 references

0 references

Kipp W

1

1 reference

7 September 2017

Bamhuhiiga J

series ordinal

2

1 reference

7 September 2017

Rubaale T

series ordinal

3

1 reference

7 September 2017

Kabagambe G

series ordinal

4

1 reference

7 September 2017

language of work or name

1 reference

1 June 2005

1 reference

Annals of Tropical Medicine and Parasitology

7 September 2017

published in

1 reference

7 September 2017

volume

99

1 reference

7 September 2017

issue

4

1 reference

7 September 2017

page(s)

395-402

1 reference

Community based distribution of ivermectin in eastern Sudan: acceptability and early post-treatment reactions

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2F136485905X36262

Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485905X36262

Increased risk of toxoplasmic encephalitis in human immunodeficiency virus-infected patients with pyrimethamine-related rash. ANRS 005-ACTG 154 Trial Group. Agence Nationale de Recherche sur le SIDA (ANRS-INSERM) and the NIAID-AIDS Clinical Trials G

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485905X36262

Adverse reactions after community treatment of onchocerciasis with ivermectin in Guatemala

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F136485905X36262

21 January 2018

Identifiers

DOI

10.1179/136485905X36262

1 reference

7 September 2017

1 reference